Table 5

PCT and the incidence of cancer
Cancer subtype All subjects Men Women
N HRa Pb N HRa Pc N HRa Pc
(95% CI) (95% CI) (95% CI)
Total cancer incidence 520 1.02 (0.93 to 1.12) 0.611 257 1.08 (0.96 to 1.21) 0.184 263 0.97 (0.86 to 1.11) 0.705
Colon 36 1.18 (0.90 to 1.55) 0.238 19 1.49 (1.13 to 1.95) 0.005** 17 0.59 (0.31 to 1.13) 0.108
Rectum 34 1.16 (0.86 to 1.57) 0.343 15 1.14 (0.71 to 1.83) 0.583 19 1.15 (0.79 to 1.67) 0.469
Lung and bronchi 43 0.95 (0.68 to 1.33) 0.764 23 0.95 (0.62 to 1.46) 0.819 20 0.96 (0.59 to 1.54) 0.864
Urinary tract 36 0.87 (0.59 to 1.27) 0.467 22 0.86 (0.55 to 1.35) 0.515 14 0.93 (0.52 to1.68) 0.815
Malignant melanoma 22 1.00 (0.64 to 1.57) 0.999 14 1.17 (0.74 to 1.87) 0.499 8 0.64 (0.26 to 1.62) 0.348
Skin (excluding melanoma) 29 0.88 (0.65 to 1.45) 0.879 19 1.12 (0.74 to 1.70) 0.600 10 0.59 (0.25 to 1.38) 0.225
Prostate 130 1.02 (0.86 to 1.21) 0.841
Breast 122 1.00 (0.83 to 1.20) 0.998

aExpressed per 1 SD increment. Cox regression analysis adjusted for age and sexb or agec. CI, confidence interval; HR, hazard ratio; PCT, procalcitonin. **P <0.01.

Cotoi et al.

Cotoi et al. BMC Medicine 2013 11:180   doi:10.1186/1741-7015-11-180

Open Data